Higher Serum Neuropeptide Y Levels Are Associated with Metabolically Unhealthy Obesity in Obese Chinese Adults: A Cross-Sectional Study
Table 3
Multivariate analysis of the association of serum NPY levels with MUO.
Exposure
Model 1
Model 2
Model 3
Model 4
OR (95% CI)
OR (95% CI)
OR (95% CI)
OR (95% CI)
NPY levels
Per 10 pg/mL increment
1.06 (1.03-1.08)
<0.0001
1.06 (1.03-1.08)
<0.0001
1.08 (1.04-1.12)
0.0003
1.07 (1.03-1.12)
0.0010
Quartile 1
1.0
1.0
1.0
1.0
Quartile 2
2.05 (0.84-5.04)
0.1171
2.35 (0.90-6.14)
0.0822
3.11 (0.70-13.73)
0.1346
2.44 (0.51-11.58)
0.2628
Quartile 3
2.75 (1.12-6.78)
0.0278
2.91 (1.11-7.59)
0.0292
5.41 (1.15-25.39)
0.0324
3.93 (0.77-20.07)
0.0994
Quartile 4
19.92 (5.86-67.71)
<0.0001
22.55 (6.29-80.87)
<0.0001
38.99 (6.18-246.01)
<0.0001
29.85 (4.38-203.62)
0.0005
trend
<0.0001
<0.0001
<0.0001
<0.0001
Model 1 was unadjusted; model 2 was adjusted for sex and age; model 3 was adjusted for model 2 plus BMI, WC, and WHR; and model 4 was adjusted for model 3 plus TC, LDL-C, and HbA1c. Quartile 1: 189.32–460.89 pg/mL, quartile 2: 460.89–559.45 pg/mL, quartile 3: 559.45–659.34 pg/mL, and quartile 4: 659.34–2097.09 pg/mL.
